Morana Jovan-embiricos - Net Worth and Insider Trading

Morana Jovan-embiricos Net Worth

The estimated net worth of Morana Jovan-embiricos is at least $125 Million dollars as of 2024-09-20. Morana Jovan-embiricos is the Director, 10% Owner of Cullinan Therapeutics Inc and owns about 6,139,339 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $110 Million. Morana Jovan-embiricos is the Director of AlloVir Inc and owns about 18,380,807 shares of AlloVir Inc (ALVR) stock worth over $15 Million. Morana Jovan-embiricos is also the 10% Owner of TCR2 Therapeutics Inc and owns about 330,238 shares of TCR2 Therapeutics Inc (TCRR) stock worth over $488,752. Details can be seen in Morana Jovan-embiricos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Morana Jovan-embiricos has not made any transactions after 2021-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Morana Jovan-embiricos

To

Morana Jovan-embiricos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Morana Jovan-embiricos owns 4 companies in total, including AlloVir Inc (ALVR) , TCR2 Therapeutics Inc (TCRR) , and Radius Health Inc (RDUS) among others .

Click here to see the complete history of Morana Jovan-embiricos’s form 4 insider trades.

Insider Ownership Summary of Morana Jovan-embiricos

Ticker Comapny Transaction Date Type of Owner
ALVR AlloVir Inc 2021-11-10 director & 10 percent owner
TCRR TCR2 Therapeutics Inc 2019-12-19 director & 10 percent owner
RDUS Radius Health Inc 2013-04-23 director & 10 percent owner
LIMIT LIMIT 2021-01-12 director & 10 percent owner

Morana Jovan-embiricos Latest Holdings Summary

Morana Jovan-embiricos currently owns a total of 3 stocks. Among these stocks, Morana Jovan-embiricos owns 6,139,339 shares of Cullinan Therapeutics Inc (CGEM) as of January 12, 2021, with a value of $110 Million and a weighting of 88.03%. Morana Jovan-embiricos owns 18,380,807 shares of AlloVir Inc (ALVR) as of November 10, 2021, with a value of $15 Million and a weighting of 11.58%. Morana Jovan-embiricos also owns 330,238 shares of TCR2 Therapeutics Inc (TCRR) as of December 19, 2019, with a value of $488,752 and a weighting of 0.39%.

Latest Holdings of Morana Jovan-embiricos

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGEM Cullinan Therapeutics Inc 2021-01-12 6,139,339 17.98 110,385,315
ALVR AlloVir Inc 2021-11-10 18,380,807 0.79 14,520,838
TCRR TCR2 Therapeutics Inc 2019-12-19 330,238 1.48 488,752

Holding Weightings of Morana Jovan-embiricos


Morana Jovan-embiricos Form 4 Trading Tracker

According to the SEC Form 4 filings, Morana Jovan-embiricos has made a total of 1 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cullinan Therapeutics Inc is the acquisition of 200,000 shares on January 12, 2021, which cost Morana Jovan-embiricos around $4 Million.

According to the SEC Form 4 filings, Morana Jovan-embiricos has made a total of 5 transactions in AlloVir Inc (ALVR) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in AlloVir Inc is the sale of 800 shares on November 10, 2021, which brought Morana Jovan-embiricos around $19,816.

According to the SEC Form 4 filings, Morana Jovan-embiricos has made a total of 4 transactions in TCR2 Therapeutics Inc (TCRR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in TCR2 Therapeutics Inc is the sale of 44,856 shares on December 19, 2019, which brought Morana Jovan-embiricos around $740,573.

Insider Trading History of Morana Jovan-embiricos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Morana Jovan-embiricos Trading Performance

GuruFocus tracks the stock performance after each of Morana Jovan-embiricos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Morana Jovan-embiricos is 0.58%. GuruFocus also compares Morana Jovan-embiricos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Morana Jovan-embiricos within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Morana Jovan-embiricos's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Morana Jovan-embiricos

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 23.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.9 LIMIT LIMIT LIMIT LIMIT LIMIT

Morana Jovan-embiricos Ownership Network

Ownership Network List of Morana Jovan-embiricos

No Data

Ownership Network Relation of Morana Jovan-embiricos

Insider Network Chart

Morana Jovan-embiricos Owned Company Details

What does AlloVir Inc do?

Who are the key executives at AlloVir Inc?

Morana Jovan-embiricos is the director & 10 percent owner of AlloVir Inc. Other key executives at AlloVir Inc include director & 10 percent owner & See Remarks Vikas Sinha , General Counsel Edward Miller , and Chief Accounting Officer Brett R Hagen .

AlloVir Inc (ALVR) Insider Trades Summary

Over the past 18 months, Morana Jovan-embiricos made no insider transaction in AlloVir Inc (ALVR). Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 179,937 shares made by Diana Brainard , a net sale of 63,273 shares made by Brett R Hagen , and a net sale of 75,271 shares made by Vikas Sinha .

In summary, during the past 3 months, insiders sold 51,312 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 51,312 shares. During the past 18 months, 338,458 shares of AlloVir Inc (ALVR) were sold and 2,930,870 shares were bought by its insiders, resulting in a net purchase of 2,592,412 shares.

AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AlloVir Inc Insider Transactions

No Available Data

Morana Jovan-embiricos Mailing Address

Above is the net worth, insider trading, and ownership report for Morana Jovan-embiricos. You might contact Morana Jovan-embiricos via mailing address: C/o Radius Health, Inc., 201 Broadway, 6th Floor, Boston Ma 02139.

Discussions on Morana Jovan-embiricos

No discussions yet.